• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission.

作者信息

Avendaño-Ortiz José, Lozano-Rodríguez Roberto, Martín-Quirós Alejandro, Terrón Verónica, Maroun-Eid Charbel, Montalbán-Hernández Karla, Valentín-Quiroga Jaime, García-Garrido Miguel Ángel, Del Val Elena Muñoz, Del Balzo-Castillo Álvaro, Peinado María, Gómez Laura, Herrero-Benito Carmen, Rubio Carolina, Casalvilla-Dueñas José Carlos, Gómez-Campelo Paloma, Pascual-Iglesias Alejandro, Del Fresno Carlos, Aguirre Luis A, López-Collazo Eduardo

机构信息

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.

出版信息

Clin Transl Med. 2021 Oct;11(10):e573. doi: 10.1002/ctm2.573.

DOI:10.1002/ctm2.573
PMID:34709745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8521292/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ea/8521292/a78795c17f85/CTM2-11-e573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ea/8521292/446aa6078146/CTM2-11-e573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ea/8521292/ab78a626a068/CTM2-11-e573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ea/8521292/a78795c17f85/CTM2-11-e573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ea/8521292/446aa6078146/CTM2-11-e573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ea/8521292/ab78a626a068/CTM2-11-e573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ea/8521292/a78795c17f85/CTM2-11-e573-g002.jpg

相似文献

1
The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission.新型冠状病毒肺炎中的免疫检查点风暴：在急诊科入院时作为严重程度标志物的作用
Clin Transl Med. 2021 Oct;11(10):e573. doi: 10.1002/ctm2.573.
2
Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections.不同可溶性免疫检查点特征可用于表征 COVID-19 严重程度、死亡率和 SARS-CoV-2 变异感染。
Front Immunol. 2024 Sep 23;15:1464480. doi: 10.3389/fimmu.2024.1464480. eCollection 2024.
3
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。
Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.
4
Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.伊朗 COVID-19 患者的细胞因子分析；与临床严重程度的关联。
Iran J Immunol. 2021 Mar;18(1):54-64. doi: 10.22034/iji.2021.87630.1810.
5
Cytokine "storm", cytokine "breeze", or both in COVID-19?细胞因子“风暴”、细胞因子“微风”，还是二者皆有？新冠疫情中的情况究竟如何？
Clin Chem Lab Med. 2020 Dec 3;59(4):637-639. doi: 10.1515/cclm-2020-1761.
6
Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer.在 Sysmex XN-10 血液分析仪上，有和无细胞因子风暴综合征的 COVID-19 患者的血细胞计数特征。
Clin Chem Lab Med. 2020 Dec 9;59(4):783-793. doi: 10.1515/cclm-2020-1529. Print 2021 Mar 26.
7
Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.循环白细胞介素-6 和白细胞介素-10 水平，而不是肿瘤坏死因子-α，作为 COVID-19 严重程度和死亡率的潜在生物标志物：系统评价与荟萃分析。
J Clin Immunol. 2021 Jan;41(1):11-22. doi: 10.1007/s10875-020-00899-z. Epub 2020 Oct 31.
8
Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.血清白细胞介素-6：墨西哥新冠病毒感染患者死亡的潜在生物标志物。
Cytokine. 2021 Jul;143:155543. doi: 10.1016/j.cyto.2021.155543. Epub 2021 Apr 17.
9
The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.新冠疫情期间一种新的细胞因子风暴的出现：儿童多系统炎症综合征。
Kaohsiung J Med Sci. 2021 Mar;37(3):255-256. doi: 10.1002/kjm2.12347. Epub 2021 Jan 5.
10
An observational study investigating soluble immune checkpoints as indicators of severe COVID-19.一项观察性研究，探讨可溶性免疫检查点作为 COVID-19 重症的指标。
Microbiol Spectr. 2024 Jul 2;12(7):e0377623. doi: 10.1128/spectrum.03776-23. Epub 2024 May 29.

引用本文的文献

1
Comprehensive immune profiling and predictive modelling of paediatric acute hepatitis of unknown aetiology from a Spanish cohort.来自西班牙队列的不明病因儿童急性肝炎的综合免疫分析和预测模型
Front Immunol. 2025 Jun 24;16:1599982. doi: 10.3389/fimmu.2025.1599982. eCollection 2025.
2
A blood-based liquid biopsy analyzing soluble immune checkpoints and cytokines identifies distinct neuroendocrine tumors.一种分析可溶性免疫检查点和细胞因子的基于血液的液体活检可识别出不同的神经内分泌肿瘤。
J Exp Clin Cancer Res. 2025 Mar 5;44(1):82. doi: 10.1186/s13046-025-03337-3.
3
Lipoxin A levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers.

本文引用的文献

1
SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.SARS-CoV-2 蛋白诱导内毒素耐受特征：COVID-19 患者的证明。
J Immunol. 2021 Jul 1;207(1):162-174. doi: 10.4049/jimmunol.2001449. Epub 2021 Jun 28.
2
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?衰老、免疫与2019冠状病毒病：年龄如何影响宿主对冠状病毒感染的免疫反应？
Front Physiol. 2021 Jan 12;11:571416. doi: 10.3389/fphys.2020.571416. eCollection 2020.
3
The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus.
脂氧素A水平与西班牙新冠病毒疾病2019队列中的疾病严重程度相关：内源性促消退介质作为生物标志物的潜在用途
Front Immunol. 2025 Jan 23;15:1509188. doi: 10.3389/fimmu.2024.1509188. eCollection 2024.
4
TIM3 in COVID-19; A potential hallmark?新冠病毒肺炎中的T细胞免疫球蛋白黏蛋白-3；一个潜在的标志？
Heliyon. 2024 Nov 13;10(23):e40386. doi: 10.1016/j.heliyon.2024.e40386. eCollection 2024 Dec 15.
5
Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections.不同可溶性免疫检查点特征可用于表征 COVID-19 严重程度、死亡率和 SARS-CoV-2 变异感染。
Front Immunol. 2024 Sep 23;15:1464480. doi: 10.3389/fimmu.2024.1464480. eCollection 2024.
6
An observational study investigating soluble immune checkpoints as indicators of severe COVID-19.一项观察性研究，探讨可溶性免疫检查点作为 COVID-19 重症的指标。
Microbiol Spectr. 2024 Jul 2;12(7):e0377623. doi: 10.1128/spectrum.03776-23. Epub 2024 May 29.
7
A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality.一项前瞻性研究调查了外周血细胞中免疫检查点分子和 CD39 的表达，以预测 COVID-19 的严重程度和死亡率。
Viruses. 2024 May 20;16(5):810. doi: 10.3390/v16050810.
8
Endotoxin tolerance and trained immunity: breaking down immunological memory barriers.内毒素耐受与训练性免疫：打破免疫记忆屏障。
Front Immunol. 2024 Apr 29;15:1393283. doi: 10.3389/fimmu.2024.1393283. eCollection 2024.
9
SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors.癌症患者接受免疫检查点抑制剂治疗时的 SARS-CoV-2 感染和 COVID-19 疫苗接种。
Cell Death Dis. 2023 Jun 30;14(6):390. doi: 10.1038/s41419-023-05922-w.
10
The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification.多黏菌素耐药性对脂多糖修饰激活固有免疫的影响。
Infect Immun. 2023 Feb 16;91(2):e0001223. doi: 10.1128/iai.00012-23. Epub 2023 Feb 1.
COVID-19 合并 2 型糖尿病患者的细胞因子谱和免疫应答增强。
J Diabetes Res. 2021 Jan 2;2021:9526701. doi: 10.1155/2021/9526701. eCollection 2021.
4
Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的蛋白质会降低T细胞增殖：脓毒症的镜像表现。
Heliyon. 2020 Dec;6(12):e05635. doi: 10.1016/j.heliyon.2020.e05635. Epub 2020 Nov 30.
5
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.SARS-CoV-2感染时代的癌症与免疫检查点抑制剂治疗
Cancers (Basel). 2020 Nov 16;12(11):3383. doi: 10.3390/cancers12113383.
6
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.托珠单抗治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21.
7
Sex differences in immune responses that underlie COVID-19 disease outcomes.COVID-19 疾病结局相关的免疫反应中的性别差异。
Nature. 2020 Dec;588(7837):315-320. doi: 10.1038/s41586-020-2700-3. Epub 2020 Aug 26.
8
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).新型冠状病毒病（COVID-19）患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
9
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.COVID-19 患者严重呼吸衰竭的复杂免疫失调。
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. doi: 10.1016/j.chom.2020.04.009. Epub 2020 Apr 21.
10
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients.外周血中T细胞的疲惫水平升高和功能多样性降低可能预示着新冠病毒疾病（COVID-19）患者病情的严重进展。
Cell Mol Immunol. 2020 May;17(5):541-543. doi: 10.1038/s41423-020-0401-3. Epub 2020 Mar 17.